13F Holdings
中文EN

NHTC NATURAL HEALTH TRENDS CORP

Wholesale-Miscellaneous Nondurable Goods · Nasdaq · SEC CIK 912061 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-16.5%
TTM net income YoY-1,107.6%
TTM EPS YoY-1,300.0%
Revenue 3-yr CAGR-9.1%
Net income 3-yr CAGR—

Margins

Gross margin74.3%
Operating margin-5.9%
Net margin-4.2%
FCF margin-13.7%
EBITDA margin-5.7%

Returns

ROE-6.9%
ROA-4.1%
ROIC (approx.)-15.3%
Asset turnover0.98x

Leverage & solvency

Liabilities / assets45.0%
Debt / equity0.00x
Current ratio2.13x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.96x
Accruals ratio8.0%
Payout ratio—
Capex / revenue1.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$39.78M$42.96M$43.92M$49.13M$60.01M
Cost of revenue$10.52M$11.18M$11.18M$12.66M$15.01M
Gross profit$29.25M$31.79M$32.75M$36.47M$44.99M
SG&A expense$14.76M$15.51M$16.01M$16.00M$17.85M
Operating income-$1.81M-$1.30M-$1.67M-$270,000$1.57M
Pretax income-$567,000$620,000$745,000$602,000$1.51M
Income tax$315,000$48,000$177,000$289,000$425,000
Net income-$882,000$572,000$568,000$313,000$1.08M
EBITDA-$1.70M-$1.17M-$1.51M-$66,000$1.87M
EPS (basic)-0.080.050.050.030.10
EPS (diluted)-0.080.050.050.030.09
Dividends declared per share0.800.800.800.800.80
Weighted avg. shares (diluted)11.50M11.49M11.46M11.42M11.42M
Balance sheet
Cash & equivalents$6.81M$13.53M$56.18M$69.67M$83.84M
Short-term investments$22.06M$30.41M$0——
Inventory$2.05M$3.27M$4.29M$4.53M$5.26M
Current assets$34.19M$50.98M$64.23M$77.55M$93.47M
PP&E, net$153,000$190,000$266,000$394,000$463,000
Total assets$38.43M$55.36M$69.09M$82.82M$98.36M
Current liabilities$13.69M$20.80M$19.98M$20.44M$24.66M
Total liabilities$15.00M$22.49M$27.49M$32.67M$38.87M
Shareholders' equity$23.43M$32.87M$41.60M$50.15M$59.49M
Cash flow statement
Operating cash flow-$6.00M-$3.37M-$4.28M-$4.85M$1.02M
Capital expenditure$68,000$57,000$46,000$143,000$225,000
Free cash flow-$6.07M-$3.42M-$4.32M-$5.00M$791,000
Investing cash flow$8.15M-$30.07M-$46,000-$143,000-$225,000
Financing cash flow-$9.21M-$9.21M-$9.21M-$9.14M-$9.14M
Depreciation & amortization$109,000$131,000$164,000$204,000$299,000
Stock-based compensation$132,000$145,000$161,000$0—
Dividends paid$9.21M$9.21M$9.21M$9.14M$9.14M

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.